Valeant to Acquire Salix for $14.5 Billion DAVID GELLES Salix Pharmaceuticals, a maker of gastrointestinal drugs, was courted by at least four potential suitors in the months leading up to the agreement. February 23, 2015 at 12:00AM http://nyti.ms/19ZFqct The New York Times Business Day Mergers, Acquisitions and Divestitures, Drugs (Pharmaceuticals)
By DAVID GELLES via NYT / Eethg. Corps. Inc. / Terrence Herschel G. Business Day http://nyti.ms/19ZFqct Valeant to Acquire Salix for $14.5 Billion February 23, 2015 at 12:00AM The New York Times
No comments:
Post a Comment
thank you